Compare Bristol-Myers Squibb Co (BMY) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Occidental Petroleum Corporation — how do they compare? Bristol-Myers Squibb Co trades at $63.61 (market cap $132.45B), while Occidental Petroleum Corporation trades at $58.51 (market cap $55.89B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.4× Occidental Petroleum Corporation's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.89%). Which is the better fit depends on your goals.
| BMY | OXY | |
|---|---|---|
Market Cap | $132.45B | $55.89B |
Sector | Health | Energy |
52-Week High | $65.89 | $66.24 |
52-Week Low | $42.60 | $38.92 |
Enterprise Value | $166.44B | $74.65B |
Dividend Yield | 3.89% | 2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
